Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-23

Clinical Trial Update: Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of efinaconazole 10% solution for onychomycosis in diabetic patients completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Efinaconazole 10% solution (efinaconazole)

Snippet

Sponsor: Western University of Health Sciences | Conditions: Onychomycosis | Phase 3 | Status: COMPLETED | Results posted: 2019-10-23